Real-world outcomes with ranibizumab in branch retinal vein occlusion: The prospective, global, LUMINOUS study

202030 citationsJournal Articlegold Open Access

Authors

Ian Pearce · University of Liverpool

Andreas Clemens · Novartis (Switzerland)

Michael H. Brent · University of Toronto

Lin Lü · Sun Yat-sen University

Roberto Gallego‐Pinazo · IVI Valencia Clinic

Angelo Maria Minnella · National Heart Foundation of Australia

Catherine Creuzot‐Garcher

Abstract

One year results from the LUMINOUS real-world study showed a clinically meaningful VA improvement with ranibizumab in treatment-naïve patients with BRVO; numerically higher VA gains were achieved in patients who received more injections and those with poor baseline VA. No new safety signals were observed.

Topics & Keywords

Retinal Diseases and Treatments Retinal and Optic Conditions Ocular Diseases and Behçet’s Syndrome

UN Sustainable Development Goals

Partnerships for the goals

Publication Details

Published in: PLoS ONE

Volume 15, Issue 6, pp. e0234739-e0234739

DOI: 10.1371/journal.pone.0234739

Field-Weighted Citation Impact: 2.70